{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:02:33Z","timestamp":1779771753929,"version":"3.53.1"},"reference-count":26,"publisher":"Palacky University Olomouc","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub","Biomed. Pap-Olomouc","BIOMEDICAL PAPERS-OLOMOUC","BIOMED PAP"],"published-print":{"date-parts":[[2013,6,21]]},"DOI":"10.5507\/bp.2011.059","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T17:37:42Z","timestamp":1322761062000},"page":"181-188","source":"Crossref","is-referenced-by-count":4,"title":["A significant proportion of patients with chronic myeloid leukemia and suboptimal response according to European Leukemia Net criteria have excellent prognosis without treatment change"],"prefix":"10.5507","volume":"157","author":[{"given":"Peter","family":"Rohon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Divoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Rozmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Friedecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jarosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Indrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3461","reference":[{"key":"ref0","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005686"},{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162388"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600565057"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.8154"},{"key":"ref5","first-page":"2009","article-title":"Clinical Practice Guidelines in Oncology: chronic myelogenous leukemia","volume":"1","author":"National Comprehensive","year":"2009","journal-title":"V"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn091"},{"key":"ref7","article-title":"ALLG). Myeloproliferative Disease Subcommittee. Australasian treatment guidelines for de novo","volume":"v1","author":"Australasian Leukemia","year":"2006","journal-title":"CML CP"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3747\/co.v13i6.124"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V114.22.1126.1126"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030513"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3864"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2896"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.10.007"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V101.2.690"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.055574"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0993"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4276"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4161\/cc.3.12.1331"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403399"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2008.12.013"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404807"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.20.1641"},{"key":"ref24","volume-title":"Outcomes of chronic myeloid leukemia patients with suboptimal response to imatinib. EHA 2011, poster No. 0696","author":"Garcia-Gutierrez","year":"2011"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2.1.81"}],"container-title":["Biomedical Papers"],"original-title":[],"link":[{"URL":"http:\/\/biomed.papers.upol.cz\/doi\/10.5507\/bp.2011.059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:11:58Z","timestamp":1779768718000},"score":1,"resource":{"primary":{"URL":"http:\/\/biomed.papers.upol.cz\/doi\/10.5507\/bp.2011.059.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,21]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6,21]]}},"URL":"https:\/\/doi.org\/10.5507\/bp.2011.059","relation":{},"ISSN":["1213-8118","1804-7521"],"issn-type":[{"value":"1213-8118","type":"print"},{"value":"1804-7521","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,21]]}}}